NCT01849341View on ClinicalTrials.gov

Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

July 31, 2014

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Roflumilast alternated days

500 mcg per day on alternate days (roflumilast 500μg eod) for 2 weeks

DRUG

Roflumilast 500 mcg per day

Trial Locations (4)

Unknown

Hospital de Jerez, Jerez de la Frontera

Hospital Universitario Reina Sofía, Córdoba

H.U. Virgen de las Nieves, Granada

Hospital Universitario Virgen Macarena, Seville

All Listed Sponsors
lead

Fundación Pública Andaluza Progreso y Salud

OTHER

NCT01849341 - Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily | Biotech Hunter | Biotech Hunter